 | • レポートコード：MRC2-11QY01557 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫毒素のグローバル市場について調査・分析したレポートです。種類別（炭疽病ベース毒素、ジフテリア毒素（DT）・DT誘導体、シュードモナスエキソトキシン（PE）・PE誘導体、リボソーム不活性化タンパク質ベース免疫毒素、リボヌクレアーゼベース免疫毒素、その他）市場規模、用途別（固形腫瘍、白血病）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫毒素の競争状況、市場シェア ・世界の免疫毒素市場：種類別市場規模 2015年-2020年（炭疽病ベース毒素、ジフテリア毒素（DT）・DT誘導体、シュードモナスエキソトキシン（PE）・PE誘導体、リボソーム不活性化タンパク質ベース免疫毒素、リボヌクレアーゼベース免疫毒素、その他） ・世界の免疫毒素市場：種類別市場規模予測 2021年-2026年（炭疽病ベース毒素、ジフテリア毒素（DT）・DT誘導体、シュードモナスエキソトキシン（PE）・PE誘導体、リボソーム不活性化タンパク質ベース免疫毒素、リボヌクレアーゼベース免疫毒素、その他） ・世界の免疫毒素市場：用途別市場規模 2015年-2020年（固形腫瘍、白血病） ・世界の免疫毒素市場：用途別市場規模予測 2021年-2026年（固形腫瘍、白血病） ・北米の免疫毒素市場分析：米国、カナダ ・ヨーロッパの免疫毒素市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫毒素市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫毒素市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫毒素市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biotest、Celldex Therapeutics、Amgen、Genmab、AREVA Med、Bayer HealthCare、Neurocrine Biosciences、Research Corporation Technologies、CuraGen Corporation、Genentech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Immunotoxins Market
The global Immunotoxins market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Immunotoxins Scope and Market Size
Immunotoxins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunotoxins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunotoxins market is segmented into
Anthrax Based Toxins
Diphtheria Toxin (DT) & DT Derivatives
Pseudomonas Exotoxin (PE) & PE Derivatives
Ribosome Inactivating Proteins Based Immunotoxins
Ribonucleases based Immunotoxins
Others
Segment by Application, the Immunotoxins market is segmented into
Solid Tumors
Leukemias
Regional and Country-level Analysis
The Immunotoxins market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunotoxins market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunotoxins Market Share Analysis
Immunotoxins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunotoxins business, the date to enter into the Immunotoxins market, Immunotoxins product introduction, recent developments, etc.
The major vendors covered:
Biotest
Celldex Therapeutics
Amgen
Genmab
AREVA Med
Bayer HealthCare
Neurocrine Biosciences
Research Corporation Technologies
CuraGen Corporation
Genentech
1 Study Coverage
1.1 Immunotoxins Product Introduction
1.2 Market Segments
1.3 Key Immunotoxins Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunotoxins Market Size Growth Rate by Type
1.4.2 Anthrax Based Toxins
1.4.3 Diphtheria Toxin (DT) & DT Derivatives
1.4.4 Pseudomonas Exotoxin (PE) & PE Derivatives
1.4.5 Ribosome Inactivating Proteins Based Immunotoxins
1.4.6 Ribonucleases based Immunotoxins
1.4.7 Others
1.5 Market by Application
1.5.1 Global Immunotoxins Market Size Growth Rate by Application
1.5.2 Solid Tumors
1.5.3 Leukemias
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunotoxins Market Size, Estimates and Forecasts
2.1.1 Global Immunotoxins Revenue 2015-2026
2.1.2 Global Immunotoxins Sales 2015-2026
2.2 Global Immunotoxins, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunotoxins Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunotoxins Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunotoxins Competitor Landscape by Players
3.1 Immunotoxins Sales by Manufacturers
3.1.1 Immunotoxins Sales by Manufacturers (2015-2020)
3.1.2 Immunotoxins Sales Market Share by Manufacturers (2015-2020)
3.2 Immunotoxins Revenue by Manufacturers
3.2.1 Immunotoxins Revenue by Manufacturers (2015-2020)
3.2.2 Immunotoxins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunotoxins Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunotoxins Revenue in 2019
3.2.5 Global Immunotoxins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunotoxins Price by Manufacturers
3.4 Immunotoxins Manufacturing Base Distribution, Product Types
3.4.1 Immunotoxins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunotoxins Product Type
3.4.3 Date of International Manufacturers Enter into Immunotoxins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunotoxins Market Size by Type (2015-2020)
4.1.1 Global Immunotoxins Sales by Type (2015-2020)
4.1.2 Global Immunotoxins Revenue by Type (2015-2020)
4.1.3 Immunotoxins Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunotoxins Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunotoxins Sales Forecast by Type (2021-2026)
4.2.2 Global Immunotoxins Revenue Forecast by Type (2021-2026)
4.2.3 Immunotoxins Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunotoxins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunotoxins Market Size by Application (2015-2020)
5.1.1 Global Immunotoxins Sales by Application (2015-2020)
5.1.2 Global Immunotoxins Revenue by Application (2015-2020)
5.1.3 Immunotoxins Price by Application (2015-2020)
5.2 Immunotoxins Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunotoxins Sales Forecast by Application (2021-2026)
5.2.2 Global Immunotoxins Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunotoxins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunotoxins by Country
6.1.1 North America Immunotoxins Sales by Country
6.1.2 North America Immunotoxins Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunotoxins Market Facts & Figures by Type
6.3 North America Immunotoxins Market Facts & Figures by Application
7 Europe
7.1 Europe Immunotoxins by Country
7.1.1 Europe Immunotoxins Sales by Country
7.1.2 Europe Immunotoxins Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunotoxins Market Facts & Figures by Type
7.3 Europe Immunotoxins Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunotoxins by Region
8.1.1 Asia Pacific Immunotoxins Sales by Region
8.1.2 Asia Pacific Immunotoxins Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunotoxins Market Facts & Figures by Type
8.3 Asia Pacific Immunotoxins Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunotoxins by Country
9.1.1 Latin America Immunotoxins Sales by Country
9.1.2 Latin America Immunotoxins Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunotoxins Market Facts & Figures by Type
9.3 Central & South America Immunotoxins Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunotoxins by Country
10.1.1 Middle East and Africa Immunotoxins Sales by Country
10.1.2 Middle East and Africa Immunotoxins Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunotoxins Market Facts & Figures by Type
10.3 Middle East and Africa Immunotoxins Market Facts & Figures by Application
11 Company Profiles
11.1 Biotest
11.1.1 Biotest Corporation Information
11.1.2 Biotest Description and Business Overview
11.1.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biotest Immunotoxins Products Offered
11.1.5 Biotest Related Developments
11.2 Celldex Therapeutics
11.2.1 Celldex Therapeutics Corporation Information
11.2.2 Celldex Therapeutics Description and Business Overview
11.2.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celldex Therapeutics Immunotoxins Products Offered
11.2.5 Celldex Therapeutics Related Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description and Business Overview
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Immunotoxins Products Offered
11.3.5 Amgen Related Developments
11.4 Genmab
11.4.1 Genmab Corporation Information
11.4.2 Genmab Description and Business Overview
11.4.3 Genmab Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Genmab Immunotoxins Products Offered
11.4.5 Genmab Related Developments
11.5 AREVA Med
11.5.1 AREVA Med Corporation Information
11.5.2 AREVA Med Description and Business Overview
11.5.3 AREVA Med Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AREVA Med Immunotoxins Products Offered
11.5.5 AREVA Med Related Developments
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Corporation Information
11.6.2 Bayer HealthCare Description and Business Overview
11.6.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer HealthCare Immunotoxins Products Offered
11.6.5 Bayer HealthCare Related Developments
11.7 Neurocrine Biosciences
11.7.1 Neurocrine Biosciences Corporation Information
11.7.2 Neurocrine Biosciences Description and Business Overview
11.7.3 Neurocrine Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Neurocrine Biosciences Immunotoxins Products Offered
11.7.5 Neurocrine Biosciences Related Developments
11.8 Research Corporation Technologies
11.8.1 Research Corporation Technologies Corporation Information
11.8.2 Research Corporation Technologies Description and Business Overview
11.8.3 Research Corporation Technologies Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Research Corporation Technologies Immunotoxins Products Offered
11.8.5 Research Corporation Technologies Related Developments
11.9 CuraGen Corporation
11.9.1 CuraGen Corporation Corporation Information
11.9.2 CuraGen Corporation Description and Business Overview
11.9.3 CuraGen Corporation Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CuraGen Corporation Immunotoxins Products Offered
11.9.5 CuraGen Corporation Related Developments
11.10 Genentech
11.10.1 Genentech Corporation Information
11.10.2 Genentech Description and Business Overview
11.10.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Genentech Immunotoxins Products Offered
11.10.5 Genentech Related Developments
11.1 Biotest
11.1.1 Biotest Corporation Information
11.1.2 Biotest Description and Business Overview
11.1.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biotest Immunotoxins Products Offered
11.1.5 Biotest Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunotoxins Market Estimates and Projections by Region
12.1.1 Global Immunotoxins Sales Forecast by Regions 2021-2026
12.1.2 Global Immunotoxins Revenue Forecast by Regions 2021-2026
12.2 North America Immunotoxins Market Size Forecast (2021-2026)
12.2.1 North America: Immunotoxins Sales Forecast (2021-2026)
12.2.2 North America: Immunotoxins Revenue Forecast (2021-2026)
12.2.3 North America: Immunotoxins Market Size Forecast by Country (2021-2026)
12.3 Europe Immunotoxins Market Size Forecast (2021-2026)
12.3.1 Europe: Immunotoxins Sales Forecast (2021-2026)
12.3.2 Europe: Immunotoxins Revenue Forecast (2021-2026)
12.3.3 Europe: Immunotoxins Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunotoxins Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunotoxins Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunotoxins Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunotoxins Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunotoxins Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunotoxins Sales Forecast (2021-2026)
12.5.2 Latin America: Immunotoxins Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunotoxins Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunotoxins Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunotoxins Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunotoxins Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunotoxins Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunotoxins Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunotoxins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Immunotoxins Market Segments
Table 2. Ranking of Global Top Immunotoxins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immunotoxins Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Anthrax Based Toxins
Table 5. Major Manufacturers of Diphtheria Toxin (DT) & DT Derivatives
Table 6. Major Manufacturers of Pseudomonas Exotoxin (PE) & PE Derivatives
Table 7. Major Manufacturers of Ribosome Inactivating Proteins Based Immunotoxins
Table 8. Major Manufacturers of Ribonucleases based Immunotoxins
Table 9. Major Manufacturers of Others
Table 10. Global Immunotoxins Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Immunotoxins Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Immunotoxins Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Immunotoxins Sales Market Share by Regions (2015-2020)
Table 14. Global Immunotoxins Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Immunotoxins Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Immunotoxins Sales Share by Manufacturers (2015-2020)
Table 17. Global Immunotoxins Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Immunotoxins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotoxins as of 2019)
Table 19. Immunotoxins Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Immunotoxins Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Immunotoxins Price (2015-2020) (USD/Pcs)
Table 22. Immunotoxins Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Immunotoxins Product Type
Table 24. Date of International Manufacturers Enter into Immunotoxins Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 27. Global Immunotoxins Sales Share by Type (2015-2020)
Table 28. Global Immunotoxins Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Immunotoxins Revenue Share by Type (2015-2020)
Table 30. Immunotoxins Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 32. Global Immunotoxins Sales Share by Application (2015-2020)
Table 33. North America Immunotoxins Sales by Country (2015-2020) (K Pcs)
Table 34. North America Immunotoxins Sales Market Share by Country (2015-2020)
Table 35. North America Immunotoxins Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Immunotoxins Revenue Market Share by Country (2015-2020)
Table 37. North America Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 38. North America Immunotoxins Sales Market Share by Type (2015-2020)
Table 39. North America Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 40. North America Immunotoxins Sales Market Share by Application (2015-2020)
Table 41. Europe Immunotoxins Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Immunotoxins Sales Market Share by Country (2015-2020)
Table 43. Europe Immunotoxins Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Immunotoxins Revenue Market Share by Country (2015-2020)
Table 45. Europe Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Immunotoxins Sales Market Share by Type (2015-2020)
Table 47. Europe Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Immunotoxins Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Immunotoxins Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Immunotoxins Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Immunotoxins Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Immunotoxins Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Immunotoxins Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Immunotoxins Sales Market Share by Application (2015-2020)
Table 57. Latin America Immunotoxins Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Immunotoxins Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Immunotoxins Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Immunotoxins Revenue Market Share by Country (2015-2020)
Table 61. Latin America Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Immunotoxins Sales Market Share by Type (2015-2020)
Table 63. Latin America Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Immunotoxins Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Immunotoxins Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Immunotoxins Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Immunotoxins Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Immunotoxins Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Immunotoxins Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Immunotoxins Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Immunotoxins Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Immunotoxins Sales Market Share by Application (2015-2020)
Table 73. Biotest Corporation Information
Table 74. Biotest Description and Major Businesses
Table 75. Biotest Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Biotest Product
Table 77. Biotest Recent Development
Table 78. Celldex Therapeutics Corporation Information
Table 79. Celldex Therapeutics Description and Major Businesses
Table 80. Celldex Therapeutics Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Celldex Therapeutics Product
Table 82. Celldex Therapeutics Recent Development
Table 83. Amgen Corporation Information
Table 84. Amgen Description and Major Businesses
Table 85. Amgen Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Amgen Product
Table 87. Amgen Recent Development
Table 88. Genmab Corporation Information
Table 89. Genmab Description and Major Businesses
Table 90. Genmab Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Genmab Product
Table 92. Genmab Recent Development
Table 93. AREVA Med Corporation Information
Table 94. AREVA Med Description and Major Businesses
Table 95. AREVA Med Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. AREVA Med Product
Table 97. AREVA Med Recent Development
Table 98. Bayer HealthCare Corporation Information
Table 99. Bayer HealthCare Description and Major Businesses
Table 100. Bayer HealthCare Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Bayer HealthCare Product
Table 102. Bayer HealthCare Recent Development
Table 103. Neurocrine Biosciences Corporation Information
Table 104. Neurocrine Biosciences Description and Major Businesses
Table 105. Neurocrine Biosciences Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Neurocrine Biosciences Product
Table 107. Neurocrine Biosciences Recent Development
Table 108. Research Corporation Technologies Corporation Information
Table 109. Research Corporation Technologies Description and Major Businesses
Table 110. Research Corporation Technologies Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Research Corporation Technologies Product
Table 112. Research Corporation Technologies Recent Development
Table 113. CuraGen Corporation Corporation Information
Table 114. CuraGen Corporation Description and Major Businesses
Table 115. CuraGen Corporation Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. CuraGen Corporation Product
Table 117. CuraGen Corporation Recent Development
Table 118. Genentech Corporation Information
Table 119. Genentech Description and Major Businesses
Table 120. Genentech Immunotoxins Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Genentech Product
Table 122. Genentech Recent Development
Table 123. Global Immunotoxins Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Immunotoxins Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Immunotoxins Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Immunotoxins Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Immunotoxins Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Immunotoxins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Immunotoxins Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Immunotoxins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Immunotoxins Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Immunotoxins Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Immunotoxins Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Immunotoxins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Immunotoxins Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Immunotoxins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Immunotoxins Players
Table 141. Immunotoxins Customers List
Table 142. Immunotoxins Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunotoxins Product Picture
Figure 2. Global Immunotoxins Sales Market Share by Type in 2020 & 2026
Figure 3. Anthrax Based Toxins Product Picture
Figure 4. Diphtheria Toxin (DT) & DT Derivatives Product Picture
Figure 5. Pseudomonas Exotoxin (PE) & PE Derivatives Product Picture
Figure 6. Ribosome Inactivating Proteins Based Immunotoxins Product Picture
Figure 7. Ribonucleases based Immunotoxins Product Picture
Figure 8. Others Product Picture
Figure 9. Global Immunotoxins Sales Market Share by Application in 2020 & 2026
Figure 10. Solid Tumors
Figure 11. Leukemias
Figure 12. Immunotoxins Report Years Considered
Figure 13. Global Immunotoxins Market Size 2015-2026 (US$ Million)
Figure 14. Global Immunotoxins Sales 2015-2026 (K Pcs)
Figure 15. Global Immunotoxins Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Immunotoxins Sales Market Share by Region (2015-2020)
Figure 17. Global Immunotoxins Sales Market Share by Region in 2019
Figure 18. Global Immunotoxins Revenue Market Share by Region (2015-2020)
Figure 19. Global Immunotoxins Revenue Market Share by Region in 2019
Figure 20. Global Immunotoxins Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Immunotoxins Revenue in 2019
Figure 22. Immunotoxins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Immunotoxins Sales Market Share by Type (2015-2020)
Figure 24. Global Immunotoxins Sales Market Share by Type in 2019
Figure 25. Global Immunotoxins Revenue Market Share by Type (2015-2020)
Figure 26. Global Immunotoxins Revenue Market Share by Type in 2019
Figure 27. Global Immunotoxins Market Share by Price Range (2015-2020)
Figure 28. Global Immunotoxins Sales Market Share by Application (2015-2020)
Figure 29. Global Immunotoxins Sales Market Share by Application in 2019
Figure 30. Global Immunotoxins Revenue Market Share by Application (2015-2020)
Figure 31. Global Immunotoxins Revenue Market Share by Application in 2019
Figure 32. North America Immunotoxins Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Immunotoxins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Immunotoxins Sales Market Share by Country in 2019
Figure 35. North America Immunotoxins Revenue Market Share by Country in 2019
Figure 36. U.S. Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Immunotoxins Market Share by Type in 2019
Figure 41. North America Immunotoxins Market Share by Application in 2019
Figure 42. Europe Immunotoxins Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Immunotoxins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Immunotoxins Sales Market Share by Country in 2019
Figure 45. Europe Immunotoxins Revenue Market Share by Country in 2019
Figure 46. Germany Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Immunotoxins Market Share by Type in 2019
Figure 57. Europe Immunotoxins Market Share by Application in 2019
Figure 58. Asia Pacific Immunotoxins Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Immunotoxins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Immunotoxins Sales Market Share by Region in 2019
Figure 61. Asia Pacific Immunotoxins Revenue Market Share by Region in 2019
Figure 62. China Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Immunotoxins Market Share by Type in 2019
Figure 85. Asia Pacific Immunotoxins Market Share by Application in 2019
Figure 86. Latin America Immunotoxins Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Immunotoxins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Immunotoxins Sales Market Share by Country in 2019
Figure 89. Latin America Immunotoxins Revenue Market Share by Country in 2019
Figure 90. Mexico Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Immunotoxins Market Share by Type in 2019
Figure 97. Latin America Immunotoxins Market Share by Application in 2019
Figure 98. Middle East and Africa Immunotoxins Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Immunotoxins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Immunotoxins Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Immunotoxins Revenue Market Share by Country in 2019
Figure 102. Turkey Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Immunotoxins Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Immunotoxins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Immunotoxins Market Share by Type in 2019
Figure 109. Middle East and Africa Immunotoxins Market Share by Application in 2019
Figure 110. North America Immunotoxins Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Immunotoxins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Immunotoxins Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Immunotoxins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Immunotoxins Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Immunotoxins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Immunotoxins Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Immunotoxins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Immunotoxins Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Immunotoxins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
ゼラチン・ゼラチン誘導体の世界市場（～2026年） Gelatin and gelatin derivatives are a form of collagen. It is obtained from animal sources such as skin, hide, and bones. Gelatin and its derivatives are mainly derived from bovine hide and porcine skin. The most commonly used production process for the manufacture of gelatin involves the subjection…- カゼイン・誘導体の世界市場（～2026年） Casein is a family of related phosphoproteins. Changing lifestyle, rising adaptation rate among growing middle class, socio economic and demographic shifts are the dominant factors of the growth for casein market over the forecast period. Market Analysis and Insights: Global Casein & Derivatives Mar…
- ココナッツオイル誘導体の世界市場（～2026年） Market Analysis and Insights: Global Coconut Oil Derivatives Market The global Coconut Oil Derivatives market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coconut Oil Derivatives Scope and Market Size Coconut Oil Derivativ…
- アクリル酸誘導体の世界市場（～2026年） Acrylic acid derivatives are important raw materials for the manufacture of a wide variety of industrial and consumer products. In the theme of sustainability, more economical methods that utilize cheaper and less toxic feedstock are urgently needed. Clean pathways can be realized through the direct…
- 卵殻膜誘導体の世界市場（～2026年） Eggshell membrane is a imperative bio-resource, which is the protein-rich membrane between egg white and the egg shell, which is generally regarded as waste, has been recently gaining traction across several engineering fields. Extraordinary properties of eggshell membrane derivatives are being leve…